1. Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control 
Allan C. Skanes, MD, FRCPC, Jeff S. Healey, MD, MSc, FRCPC, John A. Cairns, MD, FRCPC, Paul Dorian, MD, FRCPC, Anne M. Gillis, MD, FRCPC, M. Sean McMurtry, MD, PhD, FRCPC, L. Brent Mitchell, MD, FRCPC, Atul Verma, MD, FRCPC, Stanley Nattel, MD, FRCPC 
Canadian Journal of Cardiology 
Volume 28, Issue 2, Pages (March 2012)
DOI: /j.cjca
Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions

2. Figure 1
Summary of recommendations for antithrombotic agent use based on Congestive Heart Failure, Hypertension, Age > 75, Diabetes Mellitus, and Prior Stroke or Transient Ischemic Attack (CHADS2) score. Additional risk factors of age > 65, vascular disease, and female sex are integrated to increase granularity at low CHADS2 score (CHADS2 = 0). ASA, acetylsalicylic acid (aspirin); OAC, oral anticoagulant.
Canadian Journal of Cardiology  , DOI: ( /j.cjca )
Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions

3. Figure 2
A summary of our recommendations for antithrombotic management in settings of CAD. ACS, acute coronary syndrome; AF, atrial fibrillation; AFL, atrial flutter; ASA, acetylsalicylic acid (aspirin); CAD, coronary artery disease; CHADS2, Congestive Heart Failure, Hypertension, Age > 75, Diabetes Mellitus, and Prior Stroke or Transient Ischemic Attack; OAC, oral anticoagulant; PCI, percutaneous coronary intervention.
Canadian Journal of Cardiology  , DOI: ( /j.cjca )
Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions

4. Figure 3
Summary of recommendations for choice of rate-control agents for various conditions. CAD, coronary artery disease; CCB, calcium channel blocking agents; Rx, therapy.
Canadian Journal of Cardiology  , DOI: ( /j.cjca )
Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions

5. Figure 4
Summary of recommendations for choice of rhythm-control therapy in patients with normal systolic left ventricular function and no history of congestive heart failure. AV, atrioventricular; CAD, coronary artery disease; CHF, congestive heart failure; Hx, history; VT, ventricular tachycardia.
Canadian Journal of Cardiology  , DOI: ( /j.cjca )
Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions

6. Figure 5
Summary of recommendations for choice of rhythm-control therapy in patients with a history of congestive heart failure (current or remote) or left ventricular systolic dysfunction. CHF, congestive heart failure; EF, ejection fraction; Hx, history; VT, ventricular tachycardia.
Canadian Journal of Cardiology  , DOI: ( /j.cjca )
Copyright © 2012 Canadian Cardiovascular Society Terms and Conditions